Branca C, Bortolato M
Neurosci Biobehav Rev. 2024; 160:105637.
PMID: 38519023
PMC: 11121756.
DOI: 10.1016/j.neubiorev.2024.105637.
Sze Y, Brunton P
J Neuroendocrinol. 2020; 33(1):e12916.
PMID: 33270955
PMC: 7900968.
DOI: 10.1111/jne.12916.
Aleman M, Chigerwe M, Varga A, Madigan J
J Vet Intern Med. 2020; 34(6):2767-2775.
PMID: 33201530
PMC: 7694825.
DOI: 10.1111/jvim.15957.
Aleman M, McCue P, Chigerwe M, Madigan J
J Vet Intern Med. 2019; 33(5):2286-2293.
PMID: 31489708
PMC: 6766486.
DOI: 10.1111/jvim.15618.
Sze Y, Gill A, Brunton P
J Neuroendocrinol. 2018; 30(11):e12644.
PMID: 30194779
PMC: 6221110.
DOI: 10.1111/jne.12644.
Sex differences and the neurobiology of affective disorders.
Rubinow D, Schmidt P
Neuropsychopharmacology. 2018; 44(1):111-128.
PMID: 30061743
PMC: 6235863.
DOI: 10.1038/s41386-018-0148-z.
Allopregnanolone alters follicular and luteal dynamics during the estrous cycle.
Asensio J, Caceres A, Pelegrina L, Sanhueza M, Scotti L, Parborell F
Reprod Biol Endocrinol. 2018; 16(1):35.
PMID: 29636114
PMC: 5894215.
DOI: 10.1186/s12958-018-0353-y.
Blunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot study.
Crowley S, OBuckley T, Schiller C, Stuebe A, Morrow A, Girdler S
Psychopharmacology (Berl). 2016; 233(7):1299-310.
PMID: 26856852
PMC: 4803569.
DOI: 10.1007/s00213-016-4217-x.
Allopregnanolone as a mediator of affective switching in reproductive mood disorders.
Schiller C, Schmidt P, Rubinow D
Psychopharmacology (Berl). 2014; 231(17):3557-67.
PMID: 24846476
PMC: 4135022.
DOI: 10.1007/s00213-014-3599-x.
Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?.
Crowley S, Girdler S
Psychopharmacology (Berl). 2014; 231(17):3619-34.
PMID: 24756763
PMC: 4135030.
DOI: 10.1007/s00213-014-3572-8.
TBI and sex: crucial role of progesterone protecting the brain in an omega-3 deficient condition.
Tyagi E, Agrawal R, Ying Z, Gomez-Pinilla F
Exp Neurol. 2013; 253:41-51.
PMID: 24361060
PMC: 4005409.
DOI: 10.1016/j.expneurol.2013.12.004.
Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.
Doyon W, Thomas A, Ostroumov A, Dong Y, Dani J
Biochem Pharmacol. 2013; 86(8):1181-93.
PMID: 23876345
PMC: 3800178.
DOI: 10.1016/j.bcp.2013.07.007.
The reciprocal regulation of stress hormones and GABA(A) receptors.
Mody I, Maguire J
Front Cell Neurosci. 2012; 6:4.
PMID: 22319473
PMC: 3268361.
DOI: 10.3389/fncel.2012.00004.
A history of depression in women is associated with an altered GABAergic neuroactive steroid profile.
Girdler S, Lindgren M, Porcu P, Rubinow D, Johnson J, Morrow A
Psychoneuroendocrinology. 2011; 37(4):543-53.
PMID: 21890277
PMC: 3233657.
DOI: 10.1016/j.psyneuen.2011.08.004.
Tolerance to the rate-increasing and not rate-decreasing effects of pregnanolone in rats.
Eppolito A, Gerak L
Behav Pharmacol. 2010; 21(8):736-44.
PMID: 20859199
PMC: 3030679.
DOI: 10.1097/FBP.0b013e32833fa79d.
Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers.
Marx C, Trost W, Shampine L, Behm F, Giordano L, Massing M
Psychopharmacology (Berl). 2006; 186(3):462-72.
PMID: 16402195
DOI: 10.1007/s00213-005-0226-x.
Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.
Hirani K, Sharma A, Jain N, Ugale R, Chopde C
Psychopharmacology (Berl). 2005; 180(2):267-78.
PMID: 15719223
DOI: 10.1007/s00213-005-2169-7.
